| mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.023 |
0.9 |
| mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |